Certificate record
Ipamorelin, lot 3162026IPA
Bioviridian Inc. assayed lot 3162026IPA of Ipamorelin from Prime Peptides at 99.8% purity on 22 Apr 2026, reporting 10.44 mg against a 10 mg label, 4.4% above the labelled mass.
Assayed 22 Apr 2026 · Bioviridian Inc. · Prime Peptides · record id coa-primepeptides-3162026ipa
What the certificate reports
| Compound | Ipamorelin |
|---|---|
| Lot identifier | 3162026IPA |
| Purity | 99.8% |
| Labelled mass | 10 mg |
| Assayed mass | 10.44 mg |
| Difference | 4.4% above the label |
| Assay date | 22 Apr 2026 |
| Testing laboratory | Bioviridian Inc. |
| Who commissioned it | Published by the vendor. Scored as a claim, not as corroboration — only an independently commissioned assay counts as verified. |
| Source document | https://primepeptides.co/wp-content/uploads/2026/04/Ipa-April-Testing-.pdf |
Check it yourself
Bioviridian Inc. does not publish a public lookup we have been able to find, so this certificate can be read but not independently re-pulled from the laboratory. The document above is the copy the vendor published. Where a laboratory does offer a lookup, we say so and link it.
A certificate describes the sample it names and nothing else. It is not a statement about any other lot, and it is not an endorsement of the vendor or of any use of the material.
Other lots from Prime Peptides
- Retatrutide, lot 26071002 99.97% · 16 Jul 2026
- Tirzepatide, lot 26070902 99.97% · 15 Jul 2026
- Tirzepatide, lot 26070201 99.92% · 8 Jul 2026
- GHK-Cu, lot PP-6524116-P 99.48% · 3 Jun 2026
- Glutathione, lot 3152026GLU 99.8% · 24 Apr 2026
- Tirzepatide, lot 3122026TR 99.8% · 24 Apr 2026
Ipamorelin from other vendors
- Bench Grade Peptides, lot 00011/0011 99.77% · AV Analytics
- Bench Grade Peptides, lot 00011/0011 99.8% · AV Analytics
- Vial Drop Labs, lot VDL-20260827-BHEY 99.93% · KMD Analytical (KMD Group LLC)
- ZC Labs, lot ZCLa2608110024 99.85% · Freedom Diagnostics Testing
- Ascend Science, lot AS-CP10-2 99.53% · Kovera Labs and/or ILS Labs
- PeptidePlugs, lot 103-10-ZB 99.82% · Freedom Diagnostics Testing